US Equities: Trick or Treat?
We explain why we are bullish on US Equities, and identify and address the risks of damaged earnings and valuation. We think US Equities are a treat, not a trick.
We explain why we are bullish on US Equities, and identify and address the risks of damaged earnings and valuation. We think US Equities are a treat, not a trick.
Gross profitability is the key investment controversy in today’s market. We reached this conclusion after several months of creating investing frameworks, analyzing risks and sectors, and, more recently, after processing this quarter’s earnings. Here, we show three research analyses we did in the last few months all resulted in the same conclusion – the importance of gross margin expansion for subsequent stock performance.
We evaluated the efficacy of buyback yield as a signal for subsequent return among public companies. Conventional wisdom is that buybacks are a sound strategy for management teams trying to boost their earnings per share growth and subsequent stock performance. Today’s research shows that this is no longer an effective strategy.
A critical part of Trivariate’s research objective is to identify and measure portfolio risks in unique ways and to evaluate emerging risk factors. With our mantra being “if risks didn’t change anyone could do risk management” we thought timing was good to establish a framework for measuring crypto risk through the lens of US equities.
Our latest market overview: a comprehensive document containing the best of our recent work and up-to-date views.
We identify the two metrics most important for identifying consistent underperformers: consistently high accruals and poor beta-adjusted momentum. Other metrics, such as share loss, margin contraction, and downward EPS revisions do not incrementally help identify underperformers on average. We conclude the note with short ideas.
We analyzed stock behavior following the announcements of new CEOs. Stocks making new CEO announcements underperform on a volatility-adjusted basis, meaning short of some deep understanding of the new CEO’s strategy, exiting / shorting stocks with a new CEO is on average prudent. The cumulative performance takes nearly 18 months to catch up to the average stock.
Back on October 1, 2002, we initiated as the US Semiconductor analyst at Sanford C. Bernstein & Co, with a note title “Share Gainers and Margin Expanders Are Multiple Expanders”. Nineteen years later we wanted to research the relevance of share gain and margin expansion in software and semis to identify dislocated stocks that may signal an investment opportunity. Going “back to the basics” of revenue growth vs. peers and margin expansion seems timely today.
Our latest market overview: a comprehensive document containing the best of our recent work and up-to-date views.
We provide a detailed quarterly summary to help investors prepare for their quarterly investor communications as well as identify emerging risk management concerns. We break our quarterly analysis into several areas of interest: performance facts, factor efficacy, the opportunity set, corporate profitability, macro / economic developments, and data from 13F filings and insider transactions.